Search Results

GPCR scientist Ben Clements shares how positive allosteric modulators could transform opioid therapy The Power of Inclusion in the GPCR Field This episode kicks off with a celebration of early-career scientists the importance of diverse voices in the GPCR community: “It’s been a very difficult path to get more early-career scientists on the podcast. Advice for Junior Scientists: Read, Rest, Run Ben closes with wisdom for early-career researchers: “Academia

From her early doubts to designing preclinical models of fentanyl and xylazine overdose, she reflects Who Should Listen This episode is especially relevant for: GPCR drug discovery scientists Respiratory pharmacologists Addiction researchers Public health professionals Early-career scientists navigating Catherine Demery on the web LinkedIn Google Scholar University of Michigan 🎧 Listen now and see how one scientist Leave a quick review to help more scientists find the show—and help us keep improving every episode.

Michelle Halls reminds us of something every scientist eventually learns: hard work is essential, but Home → Flash News → Scientific careers are not just built on brilliance Scientific careers aren’t just built on brilliance Published on November 14, 2025 Category Dr.GPCR Podcast Scientific careers aren’ In this conversation, Michelle Halls reminds us of something every scientist eventually learns: hard GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

From his early work as a technician at Johns Hopkins Hospital to leading biology at Servo Therapeutics From Scientist to Leader At Alkermes, Sokhom took his first leadership role and finally experienced the For any scientist navigating career uncertainty—his story is both roadmap and inspiration. GPCR ecosystem , GPCR scientist network , GPCR drug discovery , GPCR training program , GPCR online course Leave a quick review to help more scientists find the show—and help us keep improving every episode.

Jacek Mokrosiński "Jacek is a Senior Scientist at Novo Nordisk specializing in molecular pharmacology They talked about their shared passion for advancing science and improving patient outcomes, and their early Jacek's Career Journey and Advice Jacek and Yamina discussed Jacek's career journey, focusing on his turn, talked about her work on melanocortin receptors and an upcoming collaboration with a postdoc scientist Leave a quick review to help more scientists find the show—and help us keep improving every episode.

Yamina Berchiche About this episode GPCRs have played a central role in my scientific career ever since Michel Bouvier’s class as an undergraduate student at the University of Montreal in early 2000. For the purposes of this presentation, I will walk you through my various career experiences and include Leave a quick review to help more scientists find the show—and help us keep improving every episode.

Mid-career, he has worked in finance and developed high-frequency trading systems. built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific Following this, he joined an early-stage medical device start-up and in 5 years was responsible for project He then returned to information engineering and has been working in machine learning for nearly 10 years Leave a quick review to help more scientists find the show—and help us keep improving every episode.

Why early-career voices are critical in GPCR drug discovery —and how lab culture makes all the difference Why early-career voices are critical in GPCR drug discovery —and how lab culture makes all the difference

Terry Kenakin—built for scientists at every level. 🟢 Building core expertise? Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug Early access begins July 1 → https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery # Terry Kenakin—built for scientists at every level. 🟢 Building core expertise? Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug

How Michelle Halls turned an unexpected summer project into a GPCR research career redefining spatial intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally

Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable Leave a quick review to help more scientists find the show—and help us keep improving every episode.

recounted Badr's Journey, Multiplexing Assays, and Collaboration Badr shared his learning process and early Lastly, they concurred on the collaborative nature of the scientific community, where scientists build lab manager to facilitate communication within their global scientific team and ensure scientists could They identified the challenges scientists, particularly students and researchers, face, such as imposter Leave a quick review to help more scientists find the show—and help us keep improving every episode.

Home → Flash News → From aspiring doctor to GPCR scientist! GPCR Podcast From aspiring doctor to GPCR scientist! intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

GPCR platform by updating your profile 🧬 Find like-minded scientists, and colleagues who work on the GPCR platform by updating your profile 🧬 Find like-minded scientists, and colleagues who work on the intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

✳️Early Bird discounts for Premium Members! ✳️Early Bird discounts for Premium Members! intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

AI and machine learning are opening new doors—but only if scientists know their tools’ limits. ever How AlphaFold is shaking up structural biology—and where it still falls short Advice for junior scientists : what really matters when building a research career Who Should Listen GPCR scientists and pharmacologists Computational chemists and structural biologists Early-career researchers exploring drug discovery Biotech Leave a quick review to help more scientists find the show—and help us keep improving every episode.

’s global platform with Celtarys’ innovative chemical biology tools, making it easier than ever for scientists s global platform with Celtarys’ innovative chemical biology tools , making it easier than ever for scientists intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

Chuck DeWeese, controller at CLP, joined the mission after pivoting from a sales career into accounting data and a scientist getting a long-awaited result. He compares entrepreneurship to a scientist’s journey: uncertainty, trial-and-error, and the necessity This realization forms a deep connection between accountants and scientists alike. Leave a quick review to help more scientists find the show—and help us keep improving every episode.

hepatic clearance, key pharmacokinetics ✅ PK-PD Modeling – Predicting drug behavior, non-linear PK ✅ Early hepatic clearance, key pharmacokinetics✅ PK-PD Modeling – Predicting drug behavior, non-linear PK✅ Early intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

Precision in early decisions determines whether your molecule moves forward or stalls. applied discovery experience from Terry Kenakin distilled into practical, modular lessons designed for scientists intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

That gap in care sparked a curiosity that became a career. His early exposure to TRPV1 channels and peripheral pain mechanisms with Dr. He joined Mount Sinai through FlexMed — bypassing the MCAT — and was torn between a career in pharma He aspires to become a physician-scientist, with a focus on translational in vitro and in vivo model Leave a quick review to help more scientists find the show—and help us keep improving every episode.

Strategic Project Management for scientists Dr. Yamina Berchiche Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird

<< Back to podcast list Strategic Partner(s) The Scientist's Compass: From Academia to Entrepreneurship Networking & Career Growth – Overcoming introversion, the importance of talking to people, and how networking Tune in to hear how Dmitry navigated his career, the challenges of studying GPCRs, and why talking to MRC Laboratory of Molecular Biology in Cambridge, UK as a postdoctoral fellow and later as a staff scientist Leave a quick review to help more scientists find the show—and help us keep improving every episode.

He also reflected on his journey from his early involvement in a university chemistry lab to his current Industry: Career Progression Discussion Yamina and John had a detailed discussion about the prospects Yamina agreed and sought advice from John on career progression in academia. John then reflected on his career, sharing key moments of realization in his scientific work and his Leave a quick review to help more scientists find the show—and help us keep improving every episode.

GPCR Podcast - The Voice of the Community Conversations with the world’s leading GPCR scientists. Exploring discoveries, careers, and ideas shaping human health. Amplify voices – Provide scientists a platform to showcase their work. Yamina Berchiche interviews leading GPCR scientists on this vibrant, entertaining podcast. I really appreciate the way the podcast educates and mentors, particularly towards junior scientists

Gabriele Kockelkoren dives into: 🔬 How GPCR trafficking shapes signaling outcomes 🚀 Career insights from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug Gabriele Kockelkoren dives into: 🔬 How GPCR trafficking shapes signaling outcomes 🚀 Career insights from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug

An ecosystem where GPCR innovation accelerated — not because of a single star scientist, but because intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally

GPCR and Celtarys joining forces, expect more visibility, more precision, and more scientific impact. intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally

Home → Flash News → "Solving financial puzzles feels just like solving scientific ones," says Joe St. intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally

The new blog takes you behind the scenes — the London trip, the early confocal experiments, the pivot intellectual property is no longer something that comes up late in the process. 👉 It has become an early , 2025 GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026 As scientists GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift You Don’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally